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Aerobic glycolysis: beyond
proliferation
William Jones and Katiuscia Bianchi*
Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Aerobic glycolysis has been generally associated with cancer cell proliferation, but
fascinating and novel data show that it is also coupled to a series of further cellular
functions. In this Mini Review, we will discuss some recent findings to illustrate newly
defined roles for this process, in particular in non-malignant cells, supporting the idea
that metabolism can be considered as an integral part of cellular signaling. Consequently,
metabolism should be regarded as a plastic and highly dynamic determinant of a wide
range of cellular specific functions.
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The term aerobic glycolyis was coined byOttoWarburg at the beginning of the nineteenth century
to explain the unconventional metabolism exhibited by tumor cells.Warburg noticed thatmalignant
cells prefer to convert glucose to lactate even in the presence of oxygen, in contrast to themetabolism
of healthy/differentiated cells, where glucose is usually converted into pyruvate and only converted
to lactate in the absence of oxygen. The conversion of glucose to lactate in anaerobic conditions
(absence of oxygen) was already known as anaerobic glycolysis and thus he defined the metabolism
of cancer cells as aerobic glycolysis, to underline that the fate of glucose is not determined by the lack
of oxygen (1). The fact that cancer cell metabolism is different from that of normal cells attracted
(and still does attract) a lot of interest, since this feature can potentially facilitate selective therapeutic
targeting of tumor cells. Currently, we also come across a growing interest in the metabolism of
non-malignant cells, particularly of those involved in the immune response. Intriguingly, recent
findings in this new field of immunometabolism showed that aerobic glycolysis can be a metabolic
choice of normal cells and that its function is not limited to supporting proliferation. It appears
that cells can modulate their metabolism to adapt to different energy requirements and signaling
events in physiological situations (see Figure 1). Thus, changes in cellular metabolism are not only
restricted to nutrient deprivation or pathological conditions. These studies also demonstrate that,
despite our fairly detailed knowledge of themap of cellular metabolic reactions, little is known about
the link between metabolism and non-metabolic cellular functions. Thus, we can pose intriguing
questions: can cellular metabolism determine seemingly unrelated cellular functions and do cells
use the modulation of their metabolism to accomplish and regulate these functions?
A Role for Aerobic Glycolysis in Vessel Sprouting
The process of vessel sprouting requires endothelial cells (ECs) to differentiate into different cell
types and act in a synchronized manner. While ECs differentiated into “stalk” cells proliferate and
sustain vessel sprouting, the EC differentiated into the “tip” cell is required at the forefront and
has a migratory phenotype. Intriguingly, from a metabolic point of view, ECs are more similar to
cancer cells than to other normal differentiated cells. ECs are highly glycolytic (it has been calculated
that up to 85% of ATP in ECs is produced by glycolysis) despite the fact that they are in immediate
contact with oxygen present in the blood (2). In agreementwith this observation, it has been reported
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FIGURE 1 | Schematic representation of the principal pathways involved
in glucose catabolism summarizing recent findings discussed in the
Mini Review (red boxes). (1) 6-phosphofructo-2-kinase/fructose-2,
6-biphosphatase 3 (PFKFB3) has a key role in regulating endothelial cells
(ECs)sprouting; (2) switching to aerobic glycolysis is important for trained
immunity in monocytes; (3) contact-inhibited fibroblasts rely on the pentose
phosphate pathway (PPP) to produce NADPH; (4) GAPDH can function as an
mRNA binding protein when not engaged in glycolysis, preventing the
production of IFNγ; (5) succinate can act as intracellular signaling molecule,
being involved in the production of IL-1β in BMDM; (6) Lactate secreted by
cancer cells can act as extracellular signaling molecule, inducing the
differentiation of macrophages into tumor-associated macrophages.
that the amount of lactate secreted by ECs does not change upon
a reduction of oxygen pressure, highlighting the fact that aerobic
glycolysis is the preferred metabolism of ECs (3). While vessel
sprouting was primarily thought to be regulated by Notch sig-
naling (4), recently, cellular metabolism has also been shown to
play a major role in the process. In particular, an important func-
tion for 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
(PFKFB3) has been proposed (2). PFKFB3 is responsible for
the formation of fructose 2,6 bisphosphate, a key regulator of
glycolysis since it acts as the allosteric activator of phospho-
fructokinase 1 (PFK1), the rate limiting enzyme that converts
fructose 6-phosphate to fructose 1-6 bisphosphate. Modulation
of the level of expression of PFKFB3 by knockdown or over-
expression changes the behavior of ECs growing in spheroids.
Knockdown of the enzyme inhibits sprouting, while its overex-
pression leads to increased glycolysis, together with more and
longer sprouts. Importantly, in mosaic spheroids formed of wild-
type and PFKFB3 knock-down cells, predominantly wild-type
cells form the tips. This preferential selection of wild-type cells
is not due to the reduced proliferation rate caused by PFKFB3
silencing, since even when cell proliferation is inhibited by MitoC
cells distribute with a similar pattern as before. Moreover, this dis-
tribution is maintained up to an initial ratio of wild-type/PFKFB3
knock-down of 9:1, indicating that presence of PFKFB3 is crucial
to develop the tip cell phenotype. Importantly, PFKFB3 deple-
tion also abrogates the effect of other factors promoting the tip
phenotype, such as inhibition of Notch signaling. Mechanisti-
cally, PFKFB3 (and other glycolytic enzymes) has been shown
to interact with actin and localize at lamellopodia, possibly to
provide fast and local ATP production, where it is required to
promote cell motility. Altogether, the role of PFKFB3 and gly-
colysis in promoting the phenotype of ECs is a clear example of
how metabolism affects cellular phenotype and function beyond
its role in proliferation. PFKFB3 seems to be also a promising
therapeutic target. The small molecule inhibitor of PFKFB3 3-
(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) reduces the
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glycolytic flux and vessel formation both in vitro (EC spheroids)
and in vivo (in zebrafish and mouse retina) (5). Intriguingly, it
has been recently shown that ECs have another rather unique
metabolic characteristic, in that they rely on fatty acid oxidation
for the production of nucleotides (6). However, this aspect of ECs
metabolism is in fact linked to supporting proliferation, and thus
lies outside the topic of this mini-review.
A Role for Aerobic Glycolysis in Trained
Immunity
The fact that monocytes and polymorphonuclear leukocytes from
peritoneal exudates rely on glycolysis as their main energy source
was described in 1963 (7). However, a crucial role for glycol-
ysis has also been recently demonstrated for the development
of “trained immunity” (8). Trained immunity can be defined as
“memory” of the innate immune response and is responsible
for mounting a non-specific “adaptive” response, challenging the
concept that the innate immune response cannot have a long-
term memory. Evidence for this process has been collected in
various in vitro and in vivo models. For example, monocytes
exposed to β-glucan (a wall component of Candida albicans)
in vitro respond to lipopolysaccharide (LPS) with greater ampli-
tude 7 days after “priming,” as the result of the activation of a
pathway involving Akt/mTOR and HIF1α. Monocytes exposed
to β-glucan for 24 h switch to aerobic glycolysis, and via epi-
genetic modification sustain this metabolic choice for at least
7 days after having being “primed.” Primed monocytes are more
responsive to LPS treatment asmeasured by the increased amount
of TNFα that they secrete when compared to un-primed cells.
Importantly, the switch to aerobic glycolysis during the first 24 h
of priming is an absolute requirement for monocytes to undergo
“training,” together with epigenetic modifications and activa-
tion of the Akt/mTOR/HIF1α pathways. The amount of lactate
secreted during β-glucan priming is not affected by treatment
with methylthioadenosine (MTA), an inhibitor of methyltrans-
ferase, or ITF2375, a histone deacetylase inhibitor, but training
is abolished by these drugs. Thus, aerobic glycolysis is not a
consequence of epigenetic modifications rather both represent
a crucial mechanism contributing to trained immunity. Mech-
anistically, it is not clear why glycolysis favors the adaptive
monocyte response. It has been suggested that it can be a swift
way to produce energy during infection, where a quick and
robust response is required (8). An intriguing hypothesis is that
metabolism could affect the epigenetic status, as demonstrated in
other instances where DNA modification depends on metabo-
lites acting as cofactors or substrates (9). Along these lines, the
ratio between α-ketoglutarate (α-KG) and succinate regulates his-
tone demethylases maintaining pluripotency of embryonic stem
cells (10).
High Level of Glucose Uptake is not Equal
to Proliferation
The observation that aerobic glycolysis was the preferred
metabolic pathway of highly proliferative cancer cells was initially
difficult to explain from an energetic point of view. Indeed, via
glycolysis/OXPHOS cells generate 36 molecules of ATP for each
molecule of glucose, while via aerobic glycolysis only 4 molecules
of ATP are produced. This apparent paradox was resolved how-
ever, by considering the metabolic requirements for proliferation
beyond ATP, including nucleotide synthesis linked to the pentose
phosphate pathway (PPP), generation of amino acids for pro-
tein synthesis, and production of lipids for membrane formation.
Importantly, most of these biosynthetic pathways branch out from
glycolysis, explaining why this process is so crucial for cellular
proliferation (11). It would therefore be logical to assume that
non-proliferating or quiescent cells would require less glycolytic
activity but, surprisingly, this does not always seem to be the
case. Indeed, fibroblasts that are pushed into a quiescent status
because of contact inhibition have a very similar glucose uptake
rate to proliferating fibroblasts (12). An in depth analysis of the
metabolism of quiescent vs. proliferative fibroblasts highlighted
some unexpected findings. Proliferating fibroblasts rely on the
PPP to generate ribose for the synthesis of nucleotides and to
produce NADPH, their TCA cycle is interrupted between citrate
and α-KG and they use glutamine as an anaplerotic substrate.
Quiescent, contact-inhibited fibroblasts also maintain an active
PPP to produce NADPH but, since they do not require nucleic
acid synthesis, the carbon skeletons are recycled back to glycol-
ysis. Their TCA cycle is completely functional and they convert
pyruvate into oxaloacetate as an anaplerotic source. Unexpect-
edly, inhibition of the PPP with dehydroepiandrosterone (DHEA)
induces cell death only in quiescent fibroblasts (albeit to a lim-
ited extent), representing a unique example of a drug that selec-
tively targets non-proliferating cells. Thus, despite being non-
proliferative, contact-inhibited fibroblasts have a very active PPP.
Lemons et al. suggest three potential explanations for their find-
ings: high levels of glucose uptake could be required to replace
potentially damaged macromolecules, NADPH produced by the
PPP could be used to generate GSH and thus confer protection
from free radicals and, lastly, fibroblasts require high glucose
levels due to their high energy consuming function, i.e., synthe-
sizing and secreting large amounts of extracellular matrix compo-
nents. Importantly, contact-inhibited fibroblasts are not a unique
example of quiescent cells with high level of glucose uptake.
Hematopoietic stem cells (HSCs) also prefer glycolysis to oxidative
phosphorylation in a metabolic pattern driven by HIF1α, but
not just consequently to the hypoxic niche were they are found
(13). Moreover HSCs’ metabolism (where mitochondrial activity
is inhibited) is important to keep the quiescent status of these
cells (14).
Aerobic Glycolysis: Regulation of Protein
Translation
So far, we have described examples where aerobic glycolysis is
not linked to proliferation. However, proliferating cells normally
switch their metabolism to aerobic glycolysis for all the reasons we
mentioned in the previous paragraph. In this section, we discuss
an example where aerobic glycolysis accompanies cellular prolif-
eration but is required for translation of signaling proteins, and
not for proliferation itself. A recent study of themetabolic changes
accompanying T cell activation (when they undergo a highly
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proliferative phase) revealed that T cells not only increase
their glycolysis rate, but they also increase their oxidative
phosphorylation in comparison to naïve T cells (15). Moreover,
in the initial 48 h of activation, T cells actually rely more on
theirmitochondria than on glycolysis, they survive and proliferate
when fed with galactose (which is not a substrate of glycoly-
sis) instead of glucose, and their proliferation and activation is
extremely sensitive to mitochondrial inhibitors. Thus at a first
glance, T cell activation seems to be independent of glycoly-
sis, so why is there an increased glycolytic rate in this phase?
In this respect, a detailed analysis of the full functional spec-
trum of activated T cells, including cytokine release, revealed
some interesting novel observations. T cells fed with galactose
instead of glucose secrete much less interferon γ (IFN-γ) and
interleukin 2 (IL-2) compared to their glycolytic counterparts.
The mechanism proposed to explain this phenotype is that a
key metabolic enzyme – glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) – can also act as an mRNA binding protein.
When glycolysis is inhibited (e.g., in galactose) the enzyme is
not engaged in its main function of converting glyceraldehyde
3-phosphate to -glycerate 1,3-bisphosphate, but rather binds to
the 30-UTR of the IFN-γ mRNA, thereby preventing its trans-
lation. These findings represent an intriguing example where
aerobic glycolysis is not required for proliferation, but can actually
regulate the synthesis of a cellular and extracellular signaling
protein.
Metabolites can be used as Signaling
Molecules
In this last section, we would like to underline that metabolites
(either directly or indirectly linked to aerobic glycolysis) can
also function as signaling molecules, reinforcing the idea that
metabolism is part of the cellular signaling network. For example,
succinate is used by bone marrow derived macrophages (BMDM)
upon LPS stimulation to induce secretion of IL-1β (16). Indeed, as
recently shown, in BMDM an increase in succinate concentration
creates a condition called “pseudohypoxia,” by repressing prolyl-
4-hyrdoxylase (PHD) activity by product inhibition, leading to
the prevention of HIF1α degradation. In turn, HIF1α can bind
to the promoter of IL-1β gene inducing its expression. Impor-
tantly, secretion of different cytokines by BMDM seems to be
controlled by different mechanisms since, for example, TNFα and
IL-6 secretion is not dependent on succinate-mediated signaling.
These data suggest that different regulatory mechanisms have
evolved to control the secretion of cytokines by macrophages to
ensure a specific response in different extracellular environments,
such as the presence of different nutrients. Finally, while succinate
functions as an intracellular signaling molecule, it appears that
metabolites can also act as extracellular messengers as observed in
the case of lactic acid. TheMedzhitov group has recently described
that lactic acid released by tumor cells induces the conversion of
macrophages to tumor- associated macrophages (TAM), which
show characteristics of M2 macrophages, via a HIF1α mediated
mechanism (17).
In conclusion, these are very exciting days for cellular
metabolism, with old paradigms being reconsidered and different
fields (such as cancer cell metabolism and immunometabolism)
contributing to unravel the essential role of this complex network
of reactions in cellular biology.
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